Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03298698

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:49.490320+00:00

Published At

2018-08-27T00:00:00+00:00

Record Updated At

2018-08-27

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Idiopathic Nephrotic Syndrome", "Minimal Change Disease", "Focal Segmental Glomerulosclerosis"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-08-27"

protocolSection.identificationModule.nctId

"NCT03298698"

protocolSection.identificationModule.officialTitle

"Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Idiopathic Nephrotic Syndrome (protocolSection.conditionsModule.conditions)
• Minimal Change Disease (protocolSection.conditionsModule.conditions)
• Focal Segmental Glomerulosclerosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.